Prediction of Risk Factors for Adverse Events After Head and Neck Vascular Recanalization Surgery Based on Machine Learning Models
The Second Affiliated Hospital of Air Force Military Medical University
1 other identifier
observational
1,300
1 country
1
Brief Summary
Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 2, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedApril 16, 2025
April 1, 2025
3.8 years
November 2, 2023
April 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
death
one year
Secondary Outcomes (1)
Recurrence of stroke
one year
Study Arms (2)
xi'an
shanxi
Interventions
Eligibility Criteria
Patients undergoing vascular recanalization surgery due to stroke
You may qualify if:
- All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
- Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
- Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
- Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
- Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
- Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk events after head and neck revascularization are 50% to 69%;
- Sign the project informed consent form
You may not qualify if:
- Patients with poor overall condition and intolerance to general anesthesia;
- Patients with mental illness or severe mental illness;
- Severe respiratory system diseases;
- Pregnant and lactating women;
- Participating in another clinical study;
- Patients with advanced tumors or those who are expected to die within one year;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tangdu Hospital
Xi'an, Shaanxi, 710038, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2023
First Posted
November 7, 2023
Study Start
January 1, 2019
Primary Completion
November 1, 2022
Study Completion
October 1, 2023
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share